Filing Details
- Accession Number:
- 0001225208-16-034012
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-05-26 10:07:56
- Reporting Period:
- 2016-05-24
- Filing Date:
- 2016-05-26
- Accepted Time:
- 2016-05-26 10:07:56
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
78003 | Pfizer Inc | PFE | Pharmaceutical Preparations (2834) | 135315170 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1174449 | V Loretta Cangialosi | Pfizer Inc.-Corp. Secretary 235 East 42Nd St. New York NY 10017 | Sr. Vice President, Controller | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-05-24 | 86,000 | $25.87 | 271,663 | No | 4 | M | Direct | |
Common Stock | Disposition | 2016-05-24 | 500 | $33.98 | 271,163 | No | 4 | S | Direct | |
Common Stock | Disposition | 2016-05-24 | 16,669 | $33.95 | 254,494 | No | 4 | S | Direct | |
Common Stock | Disposition | 2016-05-24 | 18,231 | $33.99 | 236,263 | No | 4 | S | Direct | |
Common Stock | Disposition | 2016-05-24 | 19,642 | $33.97 | 216,621 | No | 4 | S | Direct | |
Common Stock | Disposition | 2016-05-24 | 30,958 | $33.96 | 185,663 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (right to buy) | Disposition | 2016-05-24 | 86,000 | $0.00 | 86,000 | $25.87 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2010-02-22 | 2017-02-21 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 1,067 | Indirect | By Rule 16b-3 Plan |